User:SaraKathryn Kalkhoff/Sandbox 1
From Proteopedia
IntroductionThe Gastric Inhibitory Polypeptide is a ligand that can be bound to its receptor (GIP-R) to help facilitate the breakdown of glucose. This is the basis of what makes up one of the key ways that glucose is bound and broken down into different parts, including insulin, to be able to maintain blood glucose levels within the body. FunctionThe GIP receptor helps facilitate movement of glucose within a cell. [1]. TirzepatideTirzepatide has been used as a treatment for Type 2 diabetes. It is used to help treat Type 2 Diabetes, as an agonist to allow insulin to be broken down. DiseaseDiabetes is very bad for you[2]. RelevanceStructural highlights
Active SiteMain binding domains between tirzepatide and the GIP receptor would contain an arginine 190 and glutamine 220 residues to facilitate binding of the ligand. One key difference found was a point mutation at position 7 between an Isoleucine and Threonine [1], which would result in a higher affinity for the tirzepatide molecule binding onto the receptor than the ligand. References
Student ContributorsSaraKathryn Kalkhoff Camille Gaudet |